White House Confirms 230,000 Additional RSV Immunization Doses for Infants Next Month

The White House announced that 230,000 more doses of respiratory syncytial virus (RSV) immunizations will be made available for infants in January.

“On Wednesday, senior Biden-Harris Administration officials met again with manufacturers of RSV immunizations including Sanofi and AstraZeneca and their partners. They discussed the need for manufacturers to work quickly to meet demand for dose availability through the commercial market this viral season. At the urging of the Administration, manufacturers confirmed that they will make available 230,000 additional doses of RSV immunizations for infants in January,” the White House said in a Dec. 14 statement.

Beyfortus, also called nirsevimab, is an RSV vaccine manufactured by Sanofi and AstraZeneca. The vaccine was approved in July this year.


Read Full Article Here